Springbok Capital Management »

Lipocine shares owned by Springbok Capital Management

Quarter-by-quarter ownership of Lipocine (LPCN) shares owned by Springbok Capital Management from 13F filings

Historical chart of Springbok Capital Management investment in Lipocine

Tip: Access up to 7 years of quarterly data

All positions including Lipocine held by Springbok Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lipocine by Springbok Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $101k 13k 7.99

More positions owned by Springbok Capital Management

Spdr Gold Tr Gold Shs (GLD)
Brighthouse Finl (BHF)
NVIDIA Corporation (NVDA)
Penumbra (PEN)
Micron Technology (MU)
Meta Platforms Cl A (META)
Clearwater Analytics Hldgs I Cl A
Norfolk Southern (NSC)
Warner Bros Discovery Com Ser A (WBD)
Amazon (AMZN)
Chart Industries (GTLS)
PNM Resources (TXNM)
Seagate Technology Hldngs Pl Ord Shs (STX)
Arcellx Common Stock (ACLX)
Versant Media Group Com Cl A (VSNT)

View all positions for Springbok Capital Management

Top funds holding Lipocine

Ikarian Capital
Squadron Capital Management
Eversept Partners
Rosalind Advisors
Vanguard Capital Management
AIGH Capital Management
Stempoint Capital
Boothbay Fund Management
Seven Fleet Capital Management
Birchview Capital
BlackRock
Mink Brook Asset Management
Geode Capital Management
Exome Asset Management
Diadema Partners

View all funds holding Lipocine